Agile Therapeutics, Inc. ( AGRX) - Key Metrics
Stock symbol AGRX is outdated, potentially delisted? Maybe it is available on other exchange?
AGRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q2 | $0.81 | -$1.73 | $0.03 | $0.03 |
| 2024Q1 | $1.23 | $0.28 | -$0.53 | -$0.53 |
| 2023Q4 | $1.22 | -$1.51 | $0.06 | $0.06 |
| 2023Q3 | $2.26 | -$0.27 | $0.12 | $0.12 |
| 2023Q2 | $3.11 | -$2.15 | -$4.81 | -$4.81 |
AGRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q2 | ? | -0.20 |
| 2024Q1 | ? | 0.24 |
| 2023Q4 | ? | -0.32 |
| 2023Q3 | ? | -2.22 |
| 2023Q2 | ? | -0.34 |
AGRX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q2 | 2.40% | ? |
| 2024Q1 | -197.98% | ? |
| 2023Q4 | 2.98% | ? |
| 2023Q3 | 5.16% | ? |
| 2023Q2 | -163.17% | ? |
AGRX
Price: $1.51
52 week price:
Earnings Per Share: -1.70 USD
P/E Ratio: 0.21
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 296349
Ebitda: -6.6 millionMarket Capitalization: 10.0 million